Dabigatran Etexilate Recall Due to Potential Contamination
At the request of the FDA, Ascend Laboratories issued a voluntary nationwide recall of Dabigatran Etexilate Capsules, a blood thinner medication, because of potential nitrosamine contamination. Nitrosamines can form in drugs during the manufacturing, packaging, and storing stages.
Source: natlawreview.com